MicroRNAs as Prognostic Biomarkers for Atrial Fibrillation Recurrence After Catheter Ablation: Current Evidence and Future Directions
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice and is associated with significant morbidity and mortality. Even though catheter ablation has emerged as an available and effective treatment for AF, recurrence remains a significant challenge. This revie...
Saved in:
Main Authors: | Emmanouil P. Vardas, Evangelos Oikonomou, Panos E. Vardas, Dimitris Tousoulis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/32 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNAs in atrial fibrillation – have we discovered the Holy Grail or opened a Pandora’s box?
by: Alkora Ioana Balan, et al.
Published: (2025-02-01) -
Influence of catheter ablation for atrial fibrillation on atrial and ventricular functional mitral regurgitation
by: Masaharu Masuda, et al.
Published: (2022-06-01) -
Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis
by: Gonghao Li, et al.
Published: (2025-01-01) -
A Nomogram utilizing ECG P-wave parameters to predict recurrence risk following catheter ablation in paroxysmal atrial fibrillation
by: Li-juan Yu, et al.
Published: (2025-01-01) -
Telomere Length Is Associated With Adverse Atrial Remodeling in Patients With Atrial Fibrillation
by: Kabita Pradhan, et al.
Published: (2025-02-01)